Valeo Pharma Inc.

Symbol: CSE: VPH OTCQB: VPHIF
Market Cap: Private
Sector: Healthcare
Summary:

Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology, Neurodegenerative Diseases, Oncology and other specialty products. Headquartered in Kirkland, Quebec, Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization

100 + employees, fast growing specialty pharma. Licenses and acquires Canadian rights to clinically de-risked, commercial stage, proprietary drugs without R&D or clinical activities associated risks

Significant revenue growth forecasted for 2022 and beyond with peak sales from existing product portfolio expected to exceed $150M. Turning EBITDA positive later in H2 2022 and undervalued with lower tier valuation & multiples compared to industry peers